Fulcrum Therapeutics, Inc. (FULC) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Fulcrum Therapeutics, Inc. (FULC) quarterly income statement — complete revenue, gross profit & net income history

Quarterly statement

FULC Income Statement

Fulcrum Therapeutics, Inc. (FULC) annual income statement — 9-year revenue, gross profit & net income history

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21

Sales/Revenue	0	0	0	0	0	0	0	0	80M	0	871K	759K	880K	295K	685K	1.18M	1.88M	2.59M	5.06M	4.93M
Revenue Growth %	-	-	-	-	-100%	-	-100%	-100%	8990.91%	-100%	27.15%	-35.84%	-53.24%	-88.62%	-86.46%	-76.03%	-57.04%	-45.88%	19.72%	167.05%
Cost of Goods Sold	216K	338K	-300K	14.3M	300K	13.4M	369K	14.64M	17.26M	479K	508K	18.24M	17.85M	16.71M	18.57M	15.37M	25.02M	17.83M	18.91M	17.08M
COGS % of Revenue	-	-	-	-	-	-	-	-	21.58%	-	58.32%	2402.9%	2028.3%	5666.1%	2710.36%	1298.9%	1329.38%	687.92%	373.9%	346.04%
Gross Profit	-216K	-338K	300K	-14.3M	-300K	-13.4M	-369K	-14.64M	62.74M	-479K	363K	-17.48M	-16.97M	-16.42M	-17.88M	-14.18M	-23.14M	-15.24M	-13.85M	-12.14M
Gross Margin %	-	-	-	-	-	-	-	-	78.42%	-	41.68%	-2302.9%	-1928.3%	-5566.1%	-2610.36%	-1198.9%	-1229.38%	-587.92%	-273.9%	-246.04%
Gross Profit Growth %	28%	97.48%	181.3%	2.34%	-100.48%	-2698.33%	-201.65%	16.25%	469.73%	97.08%	102.03%	-23.24%	26.66%	-7.75%	-29.07%	-16.81%	-78.02%	-32%	-16.22%	11.96%
Operating Expenses	19.69M	21.85M	22.99M	7.56M	19.52M	7M	19.06M	10.49M	10.25M	29.36M	28.36M	9.96M	10.32M	11.52M	10.09M	10.17M	11.1M	10.76M	9.71M	8.63M
OpEx % of Revenue	-	-	-	-	-	-	-	-	12.81%	-	3255.45%	1312.38%	1173.07%	3905.08%	1473.28%	859.85%	589.69%	415.08%	191.87%	174.83%
Selling, General & Admin	7.46M	8.1M	7.28M	7.56M	6.83M	7M	7.72M	8.42M	10.25M	10.06M	9.36M	9.96M	10.32M	11.52M	10.13M	9.71M	11.1M	10.76M	9.71M	8.63M
SG&A % of Revenue	-	-	-	-	-	-	-	-	12.81%	-	1074.17%	1312.38%	1173.07%	3905.08%	1478.83%	820.54%	589.69%	415.08%	191.87%	174.83%
Research & Development	12.44M	14.08M	15.42M	14.3M	12.99M	13.4M	11.34M	14.64M	17.26M	19.29M	19M	18.24M	17.85M	16.71M	18.57M	15.37M	25.02M	17.83M	18.91M	17.08M
R&D % of Revenue	-	-	-	-	-	-	-	-	21.58%	-	2181.29%	2402.9%	2028.3%	5666.1%	2710.36%	1298.9%	1329.38%	687.92%	373.9%	346.04%
Other Operating Expenses	-216K	-338K	300K	-1000K	-300K	-1000K	0	-1000K	-1000K	0	0	-1000K	-1000K	-1000K	-1000K	-1000K	-1000K	-1000K	-1000K	-1000K
Operating Income	-19.91M	-22.19M	-22.69M	-21.86M	-19.82M	-20.4M	-19.43M	-25.13M	52.49M	-29.83M	-27.99M	-27.44M	-27.29M	-27.94M	-27.97M	-24.36M	-34.23M	-26M	-23.56M	-20.77M
Operating Margin %	-	-	-	-	-	-	-	-	65.61%	-	-3213.78%	-3615.28%	-3101.36%	-9471.19%	-4083.65%	-2058.75%	-1819.08%	-1003.01%	-465.78%	-420.87%
Operating Income Growth %	-0.46%	-8.74%	-16.8%	13.01%	-137.75%	31.61%	30.59%	8.43%	292.33%	-6.78%	-0.07%	-12.67%	20.28%	-7.47%	-18.74%	-17.26%	-73.94%	-52.54%	-32.45%	-8.72%
EBITDA	-19.69M	-21.85M	-22.35M	-21.51M	-19.47M	-20.05M	-19.06M	-24.76M	52.87M	-29.36M	-27.48M	-26.91M	-26.73M	-27.37M	-27.38M	-23.74M	-33.56M	-25.46M	-22.94M	-20.15M
EBITDA Margin %	-	-	-	-	-	-	-	-	66.09%	-	-3155.45%	-3545.32%	-3036.93%	-9279.32%	-3997.37%	-2007.1%	-1783.16%	-982.33%	-453.5%	-408.33%
EBITDA Growth %	-1.12%	-8.97%	-17.24%	13.11%	-136.83%	31.7%	30.65%	8%	297.82%	-7.24%	-0.37%	-13.33%	20.36%	-7.51%	-19.37%	-17.83%	-76.53%	-54.88%	-34.5%	-8.63%
D&A (Non-Cash Add-back)	216K	338K	347K	346K	344K	353K	369K	369K	376K	479K	508K	531K	567K	566K	591K	611K	676K	536K	621K	619K
EBIT	-19.91M	-18.89M	-20.33M	-19.59M	-17.3M	-17.66M	-16.57M	-23.06M	55.41M	-26.87M	-27.99M	-27.44M	-27.29M	-27.94M	-28.01M	-23.89M	-34.23M	-26M	-23.56M	-20.77M
Net Interest Income	0	0	0	0	0	0	0	0	0	0	0	0	3.51M	0	0	0	0	0	0	0
Interest Income	0	0	0	0	0	0	0	0	0	0	0	0	3.51M	0	0	0	0	0	0	0
Interest Expense	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Income/Expense	-6.27M	3.29M	2.36M	2.26M	2.52M	2.75M	2.86M	3.43M	2.92M	2.96M	3.24M	3.42M	3.51M	3.16M	1.84M	617K	165K	70K	75K	54K
Pretax Income	-26.18M	-18.89M	-20.33M	-19.59M	-17.3M	-17.66M	-16.57M	-21.7M	55.41M	-26.87M	-24.76M	-24.02M	-23.78M	-24.78M	-26.14M	-23.74M	-34.07M	-25.93M	-23.48M	-20.72M
Pretax Margin %	-	-	-	-	-	-	-	-	69.26%	-	-2842.25%	-3164.3%	-2702.61%	-8399.66%	-3815.33%	-2006.59%	-1810.31%	-1000.31%	-464.29%	-419.78%
Income Tax	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Effective Tax Rate %	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
Net Income	-26.18M	-18.89M	-20.33M	-19.59M	-17.3M	-17.66M	-16.57M	-21.7M	55.41M	-26.87M	-24.76M	-24.02M	-23.78M	-24.78M	-26.14M	-23.74M	-34.07M	-25.93M	-23.48M	-20.72M
Net Margin %	-	-	-	-	-	-	-	-	69.26%	-	-2842.25%	-3164.3%	-2702.61%	-8399.66%	-3815.33%	-2006.59%	-1810.31%	-1000.31%	-464.29%	-419.78%
Net Income Growth %	-51.36%	-7%	-22.73%	9.68%	-131.22%	34.29%	33.07%	9.66%	332.98%	-8.44%	5.28%	-1.18%	30.19%	4.43%	-11.29%	-14.59%	-73.4%	-52.53%	-32.53%	-9.25%
Net Income (Continuing)	-26.18M	-18.89M	-20.33M	-19.59M	-17.3M	-17.66M	-16.57M	-21.7M	55.41M	-26.87M	-24.76M	-24.02M	-23.78M	-24.78M	-26.14M	-23.74M	-34.07M	-25.93M	-23.48M	-20.72M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)	-0.34	-0.25	-0.31	-0.31	-0.28	-0.28	-0.31	-0.35	0.87	-0.43	-0.40	-0.39	-0.38	-0.36	-0.45	-0.52	-0.83	-0.64	-0.58	-0.57
EPS Growth %	-21.43%	10.71%	0%	11.43%	-132.18%	34.88%	22.5%	10.26%	328.95%	-19.44%	11.11%	25%	54.22%	43.75%	22.41%	8.77%	-38.33%	-18.52%	9.38%	18.57%
EPS (Basic)	-0.34	-0.25	-0.31	-0.31	-0.28	-0.28	-0.31	-0.35	0.89	-0.43	-0.40	-0.39	-0.38	-0.36	-0.45	-0.52	-0.83	-0.64	-0.58	-0.57
Diluted Shares Outstanding	76.26M	76.22M	63.35M	62.6M	62.54M	62.48M	53.95M	62.41M	63.59M	61.98M	61.87M	61.82M	61.79M	59.72M	52.08M	46.21M	40.89M	40.64M	40.58M	36.61M
Basic Shares Outstanding	76.26M	76.22M	63.35M	62.6M	62.54M	62.48M	53.95M	62.41M	62.2M	61.98M	61.87M	61.82M	61.79M	59.72M	52.08M	46.21M	40.89M	40.64M	40.58M	36.61M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-